Results 51 to 60 of about 56,943 (309)
Pediatric Blood &Cancer, EarlyView.ABSTRACT Immune effector cell‐associated hemophagocytic lymphohistiocytosis‐like syndrome (IEC‐HS) is a life‐threatening hyperinflammatory toxicity distinct from cytokine release syndrome (CRS) and neurotoxicity following chimeric antigen receptor T‐cell (CAR‐T) therapy. In a single‐institution retrospective cohort of pediatric and young adult patients
Thomas J. Galletta +6 more
wiley +1 more source
On the Relationship between R&D and Productivity: a Treatment Effect Analysis [PDF]
This study uses firm level data from two detailed surveys of Italian manufacturing firms to study the relationship between R&D expenditures and productivity growth.
Giuseppe Medda +2 more
core +2 more sources
Concept of R&D expenditures in regional models of innovation management
Економіка, управління та адмініструванняThe article addresses current issues related to expenditures on research and development (R&D) within various regional models of innovation management.
R.V. Romaniv
doaj +1 more source
HOW CORPORATE PENSIONS AFFECT STOCK RETURNS: THE ROLE OF R&D EXPENDITURES
Journal of Financial Management, Markets and Institutions, 2023 We examine the stock return implications of corporate-defined benefit pension plans in innovative U.S. firms and in R&D- and patent-sorted portfolio specifications.
M. KABIR HASSAN +3 more
doaj +1 more source
The Role of Hematopoietic Cell Transplantation in Ataxia‐Telangiectasia
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Ataxia‐telangiectasia (A‐T) is a DNA repair disorder characterized by neurodegeneration, immunodeficiency, and cancer predisposition. Hematopoietic cell transplantation (HCT) is an established therapy in related disorders such as Fanconi anemia (FA) and Nijmegen breakage syndrome (NBS), but its role in A‐T is unclear.
Laila Alkhouli +3 more
wiley +1 more source
Research and Development Expenditures and Economic Growth in the EU: A Panel Data Analysis
Economics and Business, 2016 The main aim of the paper is to investigate the empirical relationship between research and development (R&D) expenditures and economic growth in the European Union member states in the period of 2000–2013.
Freimane Rita, Bāliņa Signe
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Pediatric sarcomas are a heterogeneous group of tumors that contribute disproportionately to cancer mortality in children. Although congenital anomalies are among the strongest known risk factors for childhood cancer, the risk of specific sarcoma subtypes among affected individuals has not yet been thoroughly evaluated. Procedure We
Russ Wolters +17 more
wiley +1 more source
Supporting Survivor‐Centered Care Through Digital Health Integration
Pediatric Blood &Cancer, EarlyView.ABSTRACT Survivors of childhood cancer face barriers to receiving guideline‐based, long‐term follow‐up care. Two digital tools, Passport for Care (PFC) and Cancer SurvivorLink (SurvivorLink), address complementary gaps by enabling tailored survivorship care plan (SCP) generation, updating, storage, and sharing.
Jordan G. Marchak +15 more
wiley +1 more source
Innovation performance and R&D expenditures in Western European regions: Divergence or convergence? [PDF]
, 2018 Although Western Europe is a global leader in innovation activities among the OECD countries, these activities are not distributed evenly across NUTS 2 regions.
Halásková, Martina, Bednář, Pavel
core
Research and Development as a Basis for Technological Development in Slovenia
Mednarodno Inovativno Poslovanje, 2019 n this article, we discuss the research and development (R&D) as one of the key determinants that promote innovation, technological development and, indirectly, economic growth and the competitiveness of economies and businesses.
Peter Stanovnik, Sonja Uršič
doaj +1 more source